¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©
¼¶±ð: ²©Ê¿
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-20   

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© Hx;ij?  
.Q'/e>0  
  Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ?f1PQ  
  1¡¢Co-stimulators (or co-stimulating molecules) mNcoR^(VN  
  2¡¢NK-kB o m3$=  
  3¡¢Immunoglobulin superfamily O6rrv,+_L  
  4¡¢antigen-presenting cell (APC) rEI]{?eoF  
  5¡¢death domain !]bXHT&!R  
  6¡¢CCR and CXCR D>& ;K{!  
  7¡¢Lectin (or mitogen) eF8!}|*N  
  8¡¢Clusters of differentiation, CD) %(4G[R[  
  9¡¢B7 family tT7< V{i4  
  10¡¢Cytotoxic T lymphocyte, CTL) <0[{Tn  
  11¡¢IL-15 and IL-15 receptor (IL-15R) *SkUkqP9z  
  12¡¢MHC restriction '& L;y  
  13¡¢Affinity-chromatography Y.$InQ gL  
  14¡¢Cyctosprin A, CsA ]h (TZu  
  15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) [BS3y`c  
"cerg?ix  
  ¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Ks&~VU  
  1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 z-G|EAON"/  
  2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ?p{xt$<p  
  3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ i<D}"h|  
I\R5Cb<p  
  Èý¡¢ÎÊ´ðÌ⣨25·Ö£© $)| l#'r  
  1¡¢Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ e_J_rx  
  ѪҺ²¡Ñ§×¨Òµ£º +Ux)m4}j  
  2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
freekaobo¹Ù·½Î¢ÐŶ©ÔĺŠÕýÈ·´ð°¸:¿¼²©
°´"Ctrl+Enter"Ö±½ÓÌá½»